Clinical trialNCT05636618RecruitingPhase 1/PHASE2Interventional

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

SponsorPerspective TherapeuticsEnrollment300Bronchial Neuroendocrine TumorGastroenteropancreatic Neuroendocrine TumorMeningiomaNeuroendocrine Tumor MetastaticNeuroendocrine Tumors UnresectableParaganglioma+1 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic
Jacksonville, Florida, United States
Jason Starr, MD
Recruiting
Biogenix Molecular
Miami, Florida, United States
Frankis Almaguel, MD
Recruiting
the University of Chicago
Chicago, Illinois, United States
Chih-Yi Liao, MD
Recruiting
University of Iowa
Iowa City, Iowa, United States
Yusuf Menda, MD
Recruiting
University of Kentucky
Lexington, Kentucky, United States
Lowell Anthony, MD, FACP
Recruiting
Johns Hopkins
Baltimore, Maryland, United States
Seyed Ali Mosallaie, MD
Recruiting
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Anthony Shields, M.D., Ph.D
Recruiting
Bamf Health
Grand Rapids, Michigan, United States
Brandon Mancini, MD
Recruiting
Michigan Health Professionals
Troy, Michigan, United States
Savitha Balaraman, MD
Recruiting
Mayo Clinic
Rochester, Minnesota, United States
Thorvardur R Halfdanarson, MD
Recruiting
Washington University
St Louis, Missouri, United States
Richard Wahl, MD
Recruiting
Nebraska Cancer Specialists
Omaha, Nebraska, United States
Samuel Mehr, MD
Recruiting
University of North Carolina
Chapel Hill, North Carolina, United States
Jared Weiss, MD
Recruiting
Uh Cleveland Medical Center
Cleveland, Ohio, United States
Amr Mohamed, MD
Recruiting
Ohio State University
Columbus, Ohio, United States
Vineeth Sukrithan, M.D.
Recruiting
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Robert Ramirez, DO
Recruiting
Virginia Cancer Specialists
Fairfax, Virginia, United States
Gregory Sibley, MD
Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Amir Iranvani, MD
Recruiting
Froedtert Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Alexandria Phan, MD, FACP
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Sept 2023
Primary completion: 26 Nov 2029
Completion: 26 Dec 2029
Last update posted: 14 May 2026
Registered enrollment: 300
Registry id: NCT05636618

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.